Journal of the American Academy of Dermatology
Volume 61, Issue 1 , Pages 117-120, July 2009

Alveolar soft part sarcoma presenting with cutaneous metastases: Report of a case with immunohistochemical and molecular characterization

  • Susana Moyano, MD

      Affiliations

    • Department of Pathology, Hospital Clínic, IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer), University of Barcelona, Barcelona, Spain
  • ,
  • Paula Aguilera, MD

      Affiliations

    • Department of Dermatology, Hospital Clínic, University of Barcelona, Barcelona, Spain
  • ,
  • Anna Petit, MD

      Affiliations

    • Department of Pathology, Hospital Clínic, IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer), University of Barcelona, Barcelona, Spain
  • ,
  • Enrique de Alava, MD, PhD

      Affiliations

    • Centro de Investigación del Cáncer-IBMCC (Instituto de Biología Molecular y Celular del Cáncer), University of Salamanca-CSIC (Consejo Superior de Investigaciones Científicas), Salamanca, Spain
  • ,
  • Jose M. Mascaró, MD, PhD

      Affiliations

    • Department of Dermatology, Hospital Clínic, University of Barcelona, Barcelona, Spain
  • ,
  • Josep Palou, MD

      Affiliations

    • Department of Dermatology, Hospital Clínic, University of Barcelona, Barcelona, Spain
  • ,
  • Joan Ferrando, MD, PhD

      Affiliations

    • Department of Dermatology, Hospital Clínic, University of Barcelona, Barcelona, Spain
  • ,
  • Llucia Alos, MD, PhD

      Affiliations

    • Department of Pathology, Hospital Clínic, IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer), University of Barcelona, Barcelona, Spain
    • Corresponding Author InformationReprint requests: Llucia Alos, MD, PhD, Department of Pathology, Hospital Clínic, Villarroel 170, 08036- Barcelona, Spain.

Alveolar soft part sarcoma (ASPS) is an uncommon neoplasm of uncertain histogenesis that usually behaves as a painless, slow-growing mass that metastasizes early. We report a 21-year-old woman with cutaneous metastases of ASPS, whose histologic characteristics gave rise to a wide range of differential diagnoses of both primary and metastatic cutaneous neoplasms. The tumor failed to show a characteristic immunoprofile using routine immunohistochemical procedures, but was strongly and diffusely positive for the TFE3 antibody. The molecular study identified a type 2 alveolar soft part locus-transcription factor E3 (ASPL-TFE3) fusion, secondary to der(17)t(X;17)(p11.2;q25) translocation. A computed tomography scan performed after the diagnosis was made disclosed a 13-cm primary tumor in the left buttock. Cutaneous metastases presenting as the first sign of ASPS have not been reported previously. We emphasize the difficulties in making the diagnosis of ASPS when it presents in an unusual manner.

 

 Funding sources: None.

 Conflicts of interest: None declared.

PII: S0190-9622(08)01367-4

doi:10.1016/j.jaad.2008.10.039

Journal of the American Academy of Dermatology
Volume 61, Issue 1 , Pages 117-120, July 2009